Does NIRAPARIB Cause Thrombocytopenia? 1,041 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,041 reports of Thrombocytopenia have been filed in association with NIRAPARIB (ZEJULA). This represents 4.8% of all adverse event reports for NIRAPARIB.
1,041
Reports of Thrombocytopenia with NIRAPARIB
4.8%
of all NIRAPARIB reports
68
Deaths
413
Hospitalizations
How Dangerous Is Thrombocytopenia From NIRAPARIB?
Of the 1,041 reports, 68 (6.5%) resulted in death, 413 (39.7%) required hospitalization, and 256 (24.6%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for NIRAPARIB.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which NIRAPARIB Alternatives Have Lower Thrombocytopenia Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP